112 results
Page 2 of 6
PRE 14A
siy ekjmvtvkh8v94
21 Apr 23
Preliminary proxy
4:00pm
8-K
EX-99.2
axy9n1slf
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.1
6w4dw9sc rfcbubq2
15 Dec 22
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
8:31am
8-K
EX-99.1
b8wujyxh1 xfwrn
30 Nov 22
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
4:20pm
8-K
EX-99.2
fp2w99w3kjr1u7
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.1
lqj0rz2vjfwj
18 Oct 22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
8:30am
8-K
EX-99.2
0snx1 p8dfc6z
17 Mar 22
Synlogic Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
8:36am
8-K
EX-99.2
rpamir
10 Nov 21
Synlogic Reports Third Quarter Financial Results and Provides Business Update
8:31am
424B5
itrlth9
23 Sep 21
Prospectus supplement for primary offering
4:20pm
424B5
hji3dtbs
22 Sep 21
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.3
drcutu4cjcn07hu0
20 Sep 21
Regulation FD Disclosure
8:01am
8-K
EX-99.2
8g2z6 59ofwfhnyq
20 Sep 21
Regulation FD Disclosure
8:01am
8-K
EX-99.1
8x8l2yd06xapv
20 Sep 21
Regulation FD Disclosure
8:01am